HLA Ligand Atlas: a benign reference of HLA-presented peptides to improve T-cell-based cancer immunotherapy.
J Immunother Cancer. 2021 Apr;9(4):e002071. doi: 10.1136/jitc-2020-002071.
J Immunother Cancer. 2021.
PMID: 33858848
Free PMC article.